N-docosahexaenoylethanolamine regulates Hedgehog signaling and promotes growth of cortical axons
N-docosahexaenoylethanolamine regulates Hedgehog signaling and promotes growth of cortical axons
复制标题
DOI:
10.1242/bio.013425
复制
发表时间:
2015-12-15
期刊:
影响因子:
2.4
通讯作者:
Kim, Hee-Yong
中科院分区:
文献类型:
--
作者:
Kharebava, Giorgi;Rashid, Mohammad A.;Kim, Hee-Yong
Axonogenesis, a process for the establishment of neuron connectivity, is central to brain function. The role of metabolites derived from docosahexaenoic acid (DHA, 22:6n-3) that is specifically enriched in the brain, has not been addressed in axon development. In this study, we tested if synaptamide (N-docosahexaenoylethanolamine), an endogenous metabolite of DHA, affects axon growth in cultured cortical neurons. We found that synaptamide increased the average axon length, inhibited GLI family zinc finger 1 (GLI1) transcription and sonic hedgehog (Shh) target gene expression while inducing cAMP elevation. Similar effects were produced by cyclopamine, a regulator of the Shh pathway. Conversely, Shh antagonized elevation of cAMP and blocked synaptamide-mediated increase in axon length. Activation of Shh pathway by a smoothened (SMO) agonist (SAG) or overexpression of SMO did not inhibit axon growth mediated by synaptamide or cyclopamine. Instead, adenylate cyclase inhibitor SQ22536 abolished synaptamide-mediated axon growth indicating requirement of cAMP elevation for this process. Our findings establish that synaptamide promotes axon growth while Shh antagonizes synaptamide-mediated cAMP elevation and axon growth by a SMO-independent, non-canonical pathway.